• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E3 连接酶/ADP-核糖基转移酶 Dtx3L/Parp9 介导的泛素修饰

Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.

作者信息

Yang Chun-Song, Jividen Kasey, Spencer Adam, Dworak Natalia, Ni Li, Oostdyk Luke T, Chatterjee Mandovi, Kuśmider Beata, Reon Brian, Parlak Mahmut, Gorbunova Vera, Abbas Tarek, Jeffery Erin, Sherman Nicholas E, Paschal Bryce M

机构信息

Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee Street, Charlottesville, VA 22908, USA.

Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee Street, Charlottesville, VA 22908, USA; Department of Biochemistry and Molecular Genetics, University of Virginia, PO Box 800733, Charlottesville, VA 22908, USA.

出版信息

Mol Cell. 2017 May 18;66(4):503-516.e5. doi: 10.1016/j.molcel.2017.04.028.

DOI:10.1016/j.molcel.2017.04.028
PMID:28525742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5556935/
Abstract

ADP-ribosylation of proteins is emerging as an important regulatory mechanism. Depending on the family member, ADP-ribosyltransferases either conjugate a single ADP-ribose to a target or generate ADP-ribose chains. Here we characterize Parp9, a mono-ADP-ribosyltransferase reported to be enzymatically inactive. Parp9 undergoes heterodimerization with Dtx3L, a histone E3 ligase involved in DNA damage repair. We show that the Dtx3L/Parp9 heterodimer mediates NAD-dependent mono-ADP-ribosylation of ubiquitin, exclusively in the context of ubiquitin processing by E1 and E2 enzymes. Dtx3L/Parp9 ADP-ribosylates the carboxyl group of Ub Gly76. Because Gly76 is normally used for Ub conjugation to substrates, ADP-ribosylation of the Ub carboxyl terminus precludes ubiquitylation. Parp9 ADP-ribosylation activity therefore restrains the E3 function of Dtx3L. Mutation of the NAD binding site in Parp9 increases the DNA repair activity of the heterodimer. Moreover, poly(ADP-ribose) binding to the Parp9 macrodomains increases E3 activity. Dtx3L heterodimerization with Parp9 enables NAD and poly(ADP-ribose) regulation of E3 activity.

摘要

蛋白质的ADP核糖基化正成为一种重要的调节机制。根据家族成员的不同,ADP核糖基转移酶要么将单个ADP核糖连接到靶标上,要么生成ADP核糖链。在这里,我们对Parp9进行了表征,Parp9是一种据报道无酶活性的单ADP核糖基转移酶。Parp9与Dtx3L发生异源二聚化,Dtx3L是一种参与DNA损伤修复的组蛋白E3连接酶。我们表明,Dtx3L/Parp9异源二聚体仅在E1和E2酶进行泛素加工的背景下介导泛素的NAD依赖性单ADP核糖基化。Dtx3L/Parp9将泛素Gly76的羧基进行ADP核糖基化。由于Gly76通常用于泛素与底物的结合,泛素羧基末端的ADP核糖基化排除了泛素化。因此,Parp9的ADP核糖基化活性抑制了Dtx3L的E3功能。Parp9中NAD结合位点的突变增加了异源二聚体的DNA修复活性。此外,聚(ADP-核糖)与Parp9大结构域的结合增加了E3活性。Dtx3L与Parp9的异源二聚化使NAD和聚(ADP-核糖)能够调节E3活性。

相似文献

1
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.E3 连接酶/ADP-核糖基转移酶 Dtx3L/Parp9 介导的泛素修饰
Mol Cell. 2017 May 18;66(4):503-516.e5. doi: 10.1016/j.molcel.2017.04.028.
2
Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.DTX3L-PARP9 复合物的重建揭示了高亲和力异二聚体形成和多聚体组装的决定因素。
Biochem J. 2022 Feb 11;479(3):289-304. doi: 10.1042/BCJ20210722.
3
Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.雄激素受体的合成双半胱氨酸 ADP 核糖基化肽被 DTX3L/PARP9 复合物识别。
ACS Chem Biol. 2023 Nov 17;18(11):2377-2384. doi: 10.1021/acschembio.3c00305. Epub 2023 Nov 8.
4
Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.E3 泛素连接酶 DTX3L 的活性及其结合伙伴及其在癌症中的作用。
Biochem Soc Trans. 2022 Dec 16;50(6):1683-1692. doi: 10.1042/BST20220501.
5
Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.DTX3L 的 D2 结构域介导的寡聚化对于 DTX3L-PARP9 对单 ADP-核糖基化雄激素受体的阅读功能至关重要。
Protein Sci. 2024 Apr;33(4):e4945. doi: 10.1002/pro.4945.
6
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.PARP14 和 PARP9/DTX3L 调节干扰素诱导的 ADP-ribosylation。
EMBO J. 2024 Jul;43(14):2929-2953. doi: 10.1038/s44318-024-00126-0. Epub 2024 Jun 4.
7
Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases.结构解析 Deltex 家族 E3 泛素连接酶对泛素的 ADP-核糖基化作用
Sci Adv. 2020 Sep 18;6(38). doi: 10.1126/sciadv.abc0418. Print 2020 Sep.
8
KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.PARP9/DTX3L 和 PARP14 中的 KH 结构域协调蛋白-蛋白相互作用,促进癌细胞存活。
J Mol Biol. 2024 Feb 15;436(4):168434. doi: 10.1016/j.jmb.2023.168434. Epub 2024 Jan 3.
9
Deltex family E3 ligases specifically ubiquitinate the terminal ADP-ribose of poly(ADP-ribosyl)ation.Deltex 家族 E3 连接酶特异性泛素化聚(ADP-核糖)化的末端 ADP-核糖。
Biochem Biophys Res Commun. 2024 Aug 6;720:150101. doi: 10.1016/j.bbrc.2024.150101. Epub 2024 May 11.
10
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.SARS-CoV-2 Nsp3 宏结构域逆转干扰素信号诱导的 PARP9/DTX3L 依赖性 ADP-核糖基化。
J Biol Chem. 2021 Sep;297(3):101041. doi: 10.1016/j.jbc.2021.101041. Epub 2021 Aug 4.

引用本文的文献

1
The rise of ADP-ribose-ubiquitin.ADP-核糖-泛素的兴起
Nat Struct Mol Biol. 2025 Sep 8. doi: 10.1038/s41594-025-01651-0.
2
Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1.泛素连接酶HUWE1对类药物小分子的选择性泛素化作用。
Nat Commun. 2025 Sep 2;16(1):8182. doi: 10.1038/s41467-025-63442-x.
3
The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA repair through mutual regulation of their protein levels.E3泛素连接酶DTX3L和去泛素化酶USP28通过相互调节其蛋白质水平来微调DNA修复。
iScience. 2025 Jun 24;28(8):112990. doi: 10.1016/j.isci.2025.112990. eCollection 2025 Aug 15.
4
Parp7 generates an ADP-ribosyl degron that controls negative feedback of androgen signaling.聚(ADP-核糖)聚合酶7生成一种ADP-核糖基降解子,该降解子控制雄激素信号的负反馈。
EMBO J. 2025 Jul 18. doi: 10.1038/s44318-025-00510-4.
5
PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy.PARP9-PARP13-PARP14轴调节结直肠癌对放疗的反应。
J Exp Clin Cancer Res. 2025 Jul 11;44(1):199. doi: 10.1186/s13046-025-03439-y.
6
Serine ADPr on histones and PARP1 is a cellular target of ester-linked ubiquitylation.组蛋白和PARP1上的丝氨酸ADPr是酯连接泛素化的细胞靶点。
Nat Chem Biol. 2025 Jul 9. doi: 10.1038/s41589-025-01974-5.
7
Identification of RNF114 as ADPr-Ub reader through non-hydrolysable ubiquitinated ADP-ribose.通过不可水解的泛素化ADP-核糖鉴定RNF114作为ADP-核糖基化泛素阅读器。
Nat Commun. 2025 Jul 9;16(1):6319. doi: 10.1038/s41467-025-61111-7.
8
A family of E3 ligases extend K11 polyubiquitin on sites of MARUbylation.一个E3连接酶家族在MARU泛素化位点上延伸K11多聚泛素链。
bioRxiv. 2025 May 15:2025.05.11.653360. doi: 10.1101/2025.05.11.653360.
9
Insights into non-proteinaceous ubiquitination.对非蛋白质泛素化的见解。
Biochem Soc Trans. 2025 Apr 3;53(2):399-407. doi: 10.1042/BST20253029.
10
Shigella effector IpaH1.4 subverts host E3 ligase RNF213 to evade antibacterial immunity.志贺氏菌效应蛋白IpaH1.4破坏宿主E3连接酶RNF213以逃避抗菌免疫。
Nat Commun. 2025 Apr 1;16(1):3099. doi: 10.1038/s41467-025-58432-y.

本文引用的文献

1
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.CRL4-CDT2-SET8/p21泛素化和降解轴的失活是pevonedistat治疗黑色素瘤疗效的基础。
EBioMedicine. 2016 Aug;10:85-100. doi: 10.1016/j.ebiom.2016.06.023. Epub 2016 Jun 16.
2
Ubiquitination independent of E1 and E2 enzymes by bacterial effectors.细菌效应蛋白介导的不依赖E1和E2酶的泛素化作用
Nature. 2016 May 5;533(7601):120-4. doi: 10.1038/nature17657. Epub 2016 Apr 6.
3
Expanding the ubiquitin code through post-translational modification.通过翻译后修饰扩展泛素密码
EMBO Rep. 2015 Sep;16(9):1071-83. doi: 10.15252/embr.201540891. Epub 2015 Aug 12.
4
Mechanism of phospho-ubiquitin-induced PARKIN activation.磷酸化泛素诱导帕金森蛋白激活的机制。
Nature. 2015 Aug 20;524(7565):370-4. doi: 10.1038/nature14879. Epub 2015 Jul 10.
5
SnapShot: ADP-Ribosylation Signaling.快照:ADP-核糖基化信号转导。
Mol Cell. 2015 Jun 18;58(6):1134-1134.e1. doi: 10.1016/j.molcel.2015.06.001.
6
Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation.参与 PARP 依赖性蛋白 ADP-核糖基化合成和降解的酶的结构和机制。
Mol Cell. 2015 Jun 18;58(6):935-46. doi: 10.1016/j.molcel.2015.05.007.
7
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.从染色质到临床:PARP1抑制剂功能的分子原理
Mol Cell. 2015 Jun 18;58(6):925-34. doi: 10.1016/j.molcel.2015.04.016.
8
PARPs and ADP-Ribosylation: 50 Years … and Counting.聚(ADP-核糖)聚合酶与ADP-核糖基化:50年……且仍在继续。
Mol Cell. 2015 Jun 18;58(6):902-10. doi: 10.1016/j.molcel.2015.06.006.
9
A Clickable Aminooxy Probe for Monitoring Cellular ADP-Ribosylation.一种用于监测细胞ADP-核糖基化的可点击氨基氧基探针。
ACS Chem Biol. 2015 Aug 21;10(8):1778-84. doi: 10.1021/acschembio.5b00213. Epub 2015 May 27.
10
Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics.核 ADP-核糖基化及其在染色质重塑、细胞分化和表观遗传学中的作用。
Annu Rev Biochem. 2015;84:227-63. doi: 10.1146/annurev-biochem-060614-034506. Epub 2015 Feb 26.